Model
Edge
BioCryst Pharmaceuticals Inc
0001760020
Filing Type
4
Filing Date
11/30/2023
Updated
12/1/23, 9:40 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership